Key result
Primary percutaneous coronary intervention improved left ventricular systolic function compared to thrombolytic therapy alone or a pharmacoinvasive strategy in STEMI patients.
Why the study?
Clear evidence supporting the superiority of one reperfusion strategy over others in STEMI was lacking, and the incremental prognostic value of serial BNP measurements remained to be determined.
Does primary PCI or a pharmacoinvasive strategy improve BNP levels and LV systolic function compared to thrombolytic therapy alone in patients with acute STEMI?
Cohort (n=93)
Does primary PCI or a pharmacoinvasive strategy improve BNP levels and LV systolic function compared to thrombolytic therapy alone in patients with acute STEMI?
Answers are grounded in this paper and cite their sources.
Primary PCI is associated with significant recovery of LV systolic function at 6 months compared to thrombolytic therapy alone in patients with acute STEMI.
Background: Until now there is no clear evidence to support the superiority of one strategy over the others to treat STEMI patients.Serial B‐type natriuretic peptide (BNP) measurements accurately predict the risk of death or congestive heart failure in STEMI patients. Objective: The aim of the study was to determine which strategy is the best strategy to treat acute STEMI and if BNP give an incremental prognostic value in treated STEMI patients.Patients presented with acute STEMI were enrolled in the present study. Patients and methods: Only 93 patients were followed up with us for 6 months and divided to 3 groups according to the treatment strategy. All patient underwent BNP analysis, echocardiography and treated with either received only thrombolytic therapy (Group I), primary PCI (Group II) or received thrombolytic therapy then went to catheterization (Group III). Results: Regarding BNP level change was higher in Group I and in Group III had high BNP level higher than Group II but this difference doesn`t reach level for statistically significant correlation between BNP levels and type of reperfusion in the three groups. Regarding LV systolic function, there was no statistically difference between the percent change in LV systolic function in Group I and Group III (P-value = 0.854, 0.152 respectively) but there was statistically significant difference between the percent change in LV systolic function in Group II (P-value=0.031). Conclusion: The best way for treatment of acute STEMI patients, is a primary PCI the most significant predictive methods are recovery of EF% and reduction of BNP, however pharmacoinavsive strategy like PCI strategy has good follow up prognosis and better than thrombolytic alone therapy.
No takes yet. Share an insight, caveat, or question.
Ammar et al. (2022) conducted a cohort in Acute Myocardial Infarction (STEMI) (n=93). Primary PCI and Pharmacoinvasive strategy vs. Thrombolytic therapy alone was evaluated on Percent change in left ventricular systolic function (p=0.031). Primary percutaneous coronary intervention improved left ventricular systolic function compared to thrombolytic therapy alone or a pharmacoinvasive strategy in STEMI patients.
Synapse has enriched 10 related papers. Consider them for comparative context: